{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:22:28Z","timestamp":1788916948718,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T00:00:00Z","timestamp":1567641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Innsbruck and Medical University of Innsbruck"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00330-019-06399-y","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T16:49:58Z","timestamp":1567788598000},"page":"950-960","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Feasibility, safety, and long-term efficacy of stereotactic radiofrequency ablation for tumors adjacent to the diaphragm in the hepatic dome: a case-control study"],"prefix":"10.1007","volume":"30","author":[{"given":"Peter","family":"Schullian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Putzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Laimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0021-5792","authenticated-orcid":false,"given":"Reto","family":"Bale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,5]]},"reference":[{"key":"6399_CR1","doi-asserted-by":"crossref","unstructured":"European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908\u2013943","DOI":"10.1016\/j.jhep.2011.12.001"},{"key":"6399_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1148\/radiol.14132958","volume":"273","author":"M Ahmed","year":"2014","unstructured":"Ahmed M, Solbiati L, Brace CL et al (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology 273:241\u2013260","journal-title":"Radiology"},{"key":"6399_CR3","doi-asserted-by":"publisher","first-page":"758","DOI":"10.2214\/AJR.09.2954","volume":"195","author":"YS Kim","year":"2010","unstructured":"Kim YS, Lee WJ, Rhim H, Lim HK, Choi D, Lee JY (2010) The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol 195:758\u2013765","journal-title":"AJR Am J Roentgenol"},{"key":"6399_CR4","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1148\/radiol.2433060157","volume":"243","author":"HW Head","year":"2007","unstructured":"Head HW, Dodd GD 3rd, Dalrymple NC et al (2007) Percutaneous radiofrequency ablation of hepatic tumors against the diaphragm: frequency of diaphragmatic injury. Radiology 243:877\u2013884","journal-title":"Radiology"},{"key":"6399_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejrad.2006.05.002","volume":"60","author":"YK Kim","year":"2006","unstructured":"Kim YK, Kim CS, Lee JM, Chung GH, Chon SB (2006) Efficacy and safety of radiofrequency ablation of hepatocellular carcinoma in the hepatic dome with the CT-guided extrathoracic transhepatic approach. Eur J Radiol 60:100\u2013107","journal-title":"Eur J Radiol"},{"key":"6399_CR6","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jvir.2009.01.004","volume":"20","author":"BJ Park","year":"2009","unstructured":"Park BJ, Byun JH, Jin YH et al (2009) CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety. J Vasc Interv Radiol 20:490\u2013499","journal-title":"J Vasc Interv Radiol"},{"key":"6399_CR7","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1097\/01.RVI.0000132297.97113.C4","volume":"15","author":"T Shibata","year":"2004","unstructured":"Shibata T, Maetani Y, Kubo T, Itoh K, Togashi K, Hiraoka M (2004) Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome. J Vasc Interv Radiol 15:1323\u20131327","journal-title":"J Vasc Interv Radiol"},{"key":"6399_CR8","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3748\/wjg.v12.i4.608","volume":"12","author":"M Toyoda","year":"2006","unstructured":"Toyoda M, Kakizaki S, Horiuchi K et al (2006) Computed tomography-guided transpulmonary radiofrequency ablation for hepatocellular carcinoma located in hepatic dome. World J Gastroenterol 12:608\u2013611","journal-title":"World J Gastroenterol"},{"key":"6399_CR9","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1007\/s00330-009-1463-x","volume":"19","author":"I Song","year":"2009","unstructured":"Song I, Rhim H, Lim HK, Kim YS, Choi D (2009) Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol 19:2630\u20132640","journal-title":"Eur Radiol"},{"key":"6399_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.surg.2008.03.020","volume":"144","author":"JY Cho","year":"2008","unstructured":"Cho JY, Han HS, Yoon YS, Shin SH (2008) Feasibility of laparoscopic liver resection for tumors located in the posterosuperior segments of the liver, with a special reference to overcoming current limitations on tumor location. Surgery 144:32\u201338","journal-title":"Surgery"},{"key":"6399_CR11","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00535-003-1181-0","volume":"38","author":"T Hori","year":"2003","unstructured":"Hori T, Nagata K, Hasuike S et al (2003) Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 38:977\u2013981","journal-title":"J Gastroenterol"},{"key":"6399_CR12","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1872-034X.2011.00841.x","volume":"41","author":"K Shirai","year":"2011","unstructured":"Shirai K, Tamai H, Shingaki N et al (2011) Clinical features and risk factors of extrahepatic seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Hepatol Res 41:738\u2013745","journal-title":"Hepatol Res"},{"key":"6399_CR13","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/hep.21164","volume":"43","author":"T Teratani","year":"2006","unstructured":"Teratani T, Yoshida H, Shiina S et al (2006) Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 43:1101\u20131108","journal-title":"Hepatology"},{"key":"6399_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3109\/13645706.2010.533923","volume":"20","author":"G Widmann","year":"2011","unstructured":"Widmann G, Schullian P, Haidu M, Fasser M, Bale R (2011) Targeting accuracy of CT-guided stereotaxy for radiofrequency ablation of liver tumours. Minim Invasive Ther Allied Technol 20:218\u2013225","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"6399_CR15","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1007\/s00270-010-9966-z","volume":"34","author":"R Bale","year":"2011","unstructured":"Bale R, Widmann G, Haidu M (2011) Stereotactic radiofrequency ablation. Cardiovasc Intervent Radiol 34:852\u2013856","journal-title":"Cardiovasc Intervent Radiol"},{"key":"6399_CR16","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s00330-011-2314-0","volume":"22","author":"R Bale","year":"2012","unstructured":"Bale R, Widmann G, Schullian P et al (2012) Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases. Eur Radiol 22:930\u2013937","journal-title":"Eur Radiol"},{"key":"6399_CR17","doi-asserted-by":"publisher","first-page":"S293","DOI":"10.1097\/01.RVI.0000094601.83406.e1","volume":"14","author":"RA Omary","year":"2003","unstructured":"Omary RA, Bettmann MA, Cardella JF et al (2003) Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol 14:S293\u2013S295","journal-title":"J Vasc Interv Radiol"},{"key":"6399_CR18","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1007\/s00270-018-2007-z","volume":"41","author":"VD Vo Chieu","year":"2018","unstructured":"Vo Chieu VD, Werncke T, Hensen B, Wacker F, Ringe KI (2018) CT-guided microwave ablation of liver tumors in anatomically challenging locations. Cardiovasc Intervent Radiol 41:1520\u20131529","journal-title":"Cardiovasc Intervent Radiol"},{"key":"6399_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00261-008-9408-4","volume":"34","author":"H Rhim","year":"2009","unstructured":"Rhim H, Lim HK (2009) Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: the value of artificial ascites. Abdom Imaging 34:371\u2013380","journal-title":"Abdom Imaging"},{"key":"6399_CR20","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1038\/s41598-017-03831-5","volume":"7","author":"JF Tu","year":"2017","unstructured":"Tu JF, Ding YH, Chen L et al (2017) Iodine-125 brachytherapy prophylaxis after radiofrequency ablation cannot benefit patients in high risk of locoregional hepatocellular carcinoma recurrence. Sci Rep 7:3689","journal-title":"Sci Rep"},{"issue":"5","key":"6399_CR21","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1007\/s00330-018-5868-2","volume":"29","author":"Dong Ik Cha","year":"2018","unstructured":"Cha DI, Kang TW, Song KD et al (2018) Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure. Eur Radiol. \nhttps:\/\/doi.org\/10.1007\/s00330-018-5868-2","journal-title":"European Radiology"},{"key":"6399_CR22","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jvir.2016.01.010","volume":"27","author":"NH Asvadi","year":"2016","unstructured":"Asvadi NH, Anvari A, Uppot RN, Thabet A, Zhu AX, Arellano RS (2016) CT-guided percutaneous microwave ablation of tumors in the hepatic dome: assessment of efficacy and safety. J Vasc Interv Radiol 27:496\u2013502 quiz 503","journal-title":"J Vasc Interv Radiol"},{"key":"6399_CR23","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1111\/j.1365-2036.2006.02932.x","volume":"23","author":"PM Lopez","year":"2006","unstructured":"Lopez PM, Villanueva A, Llovet JM (2006) Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials. Aliment Pharmacol Ther 23:1535\u20131547","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"6399_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000122599","volume":"51","author":"S Kitai","year":"2008","unstructured":"Kitai S, Kudo M, Minami Y et al (2008) A new prognostic staging system for hepatocellular carcinoma: value of the biomarker combined Japan integrated staging score. Intervirology 51(Suppl 1):86\u201394","journal-title":"Intervirology"},{"key":"6399_CR25","first-page":"8","volume":"48","author":"R Lencioni","year":"2001","unstructured":"Lencioni R, Cioni D, Donati F, Bartolozzi C (2001) Combination of interventional therapies in hepatocellular carcinoma. Hepatogastroenterology 48:8\u201314","journal-title":"Hepatogastroenterology"},{"key":"6399_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-230X-14-11","volume":"14","author":"L Zhang","year":"2014","unstructured":"Zhang L, Yin X, Gan YH et al (2014) Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria. BMC Gastroenterol 14:11","journal-title":"BMC Gastroenterol"},{"key":"6399_CR27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/rcs.343","volume":"6","author":"G Widmann","year":"2010","unstructured":"Widmann G, Schullian P, Haidu M, Wiedermann FJ, Bale R (2010) Respiratory motion control for stereotactic and robotic liver interventions. Int J Med Robot 6:343\u2013349","journal-title":"Int J Med Robot"},{"issue":"3","key":"6399_CR28","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/hep.30406","volume":"70","author":"Reto Bale","year":"2019","unstructured":"Bale R, Schullian P, Eberle G et al (2018) Stereotactic radiofrequency ablation of hepatocellular carcinoma - a histopathological study in explanted livers. Hepatology. \nhttps:\/\/doi.org\/10.1002\/hep.30406","journal-title":"Hepatology"},{"key":"6399_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2214\/AJR.07.2384","volume":"190","author":"H Rhim","year":"2008","unstructured":"Rhim H, Lim HK, Kim YS, Choi D (2008) Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. AJR Am J Roentgenol 190:91\u201398","journal-title":"AJR Am J Roentgenol"},{"key":"6399_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213","journal-title":"Ann Surg"},{"key":"6399_CR31","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1046\/j.1365-2168.2002.02168.x","volume":"89","author":"S Mulier","year":"2002","unstructured":"Mulier S, Mulier P, Ni Y et al (2002) Complications of radiofrequency coagulation of liver tumours. Br J Surg 89:1206\u20131222","journal-title":"Br J Surg"},{"key":"6399_CR32","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.amjsurg.2004.09.010","volume":"189","author":"H Kaneko","year":"2005","unstructured":"Kaneko H, Takagi S, Otsuka Y et al (2005) Laparoscopic liver resection of hepatocellular carcinoma. Am J Surg 189:190\u2013194","journal-title":"Am J Surg"},{"key":"6399_CR33","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1007\/s00464-017-5835-z","volume":"32","author":"M D'Hondt","year":"2018","unstructured":"D'Hondt M, Tamby E, Boscart I et al (2018) Laparoscopic versus open parenchymal preserving liver resections in the posterosuperior segments: a case-matched study. Surg Endosc 32:1478\u20131485","journal-title":"Surg Endosc"},{"key":"6399_CR34","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/SLA.0b013e3181bcaf63","volume":"250","author":"D Castaing","year":"2009","unstructured":"Castaing D, Vibert E, Ricca L, Azoulay D, Adam R, Gayet B (2009) Oncologic results of laparoscopic versus open hepatectomy for colorectal liver metastases in two specialized centers. Ann Surg 250:849\u2013855","journal-title":"Ann Surg"},{"key":"6399_CR35","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1007\/s00464-015-4214-x","volume":"29","author":"L Xiao","year":"2015","unstructured":"Xiao L, Xiang LJ, Li JW, Chen J, Fan YD, Zheng SG (2015) Laparoscopic versus open liver resection for hepatocellular carcinoma in posterosuperior segments. Surg Endosc 29:2994\u20133001","journal-title":"Surg Endosc"},{"issue":"2","key":"6399_CR36","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jvir.2017.09.027","volume":"29","author":"Reto Bale","year":"2018","unstructured":"Bale R, Richter M, D\u00fcnser M, Levy E, Buchberger W, Schullian P (2018) Stereotactic radiofrequency ablation for breast cancer liver metastases. J Vasc Interv Radiol 29:262\u2013267","journal-title":"Journal of Vascular and Interventional Radiology"},{"key":"6399_CR37","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1007\/s00270-011-0288-6","volume":"35","author":"M Haidu","year":"2012","unstructured":"Haidu M, Dobrozemsky G, Schullian P et al (2012) Stereotactic radiofrequency ablation of unresectable intrahepatic cholangiocarcinomas: a retrospective study. Cardiovasc Intervent Radiol 35:1074\u20131082","journal-title":"Cardiovasc Intervent Radiol"},{"key":"6399_CR38","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1007\/s00270-016-1336-z","volume":"39","author":"R Bale","year":"2016","unstructured":"Bale R, Schullian P, Schmuth M, Widmann G, Jaschke W, Weinlich G (2016) Stereotactic radiofrequency ablation for metastatic melanoma to the liver. Cardiovasc Intervent Radiol 39:1128\u20131135","journal-title":"Cardiovasc Intervent Radiol"},{"key":"6399_CR39","first-page":"216 e211","volume":"73","author":"SS Kim","year":"2018","unstructured":"Kim SS, Kang TW, Kim M et al (2018) Initial radiofrequency ablation failure for hepatocellular carcinoma: repeated radiofrequency ablation versus transarterial chemoembolisation. Clin Radiol 73:216 e211\u2013216 e218","journal-title":"Clin Radiol"},{"issue":"9319","key":"6399_CR40","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","volume":"359","author":"Josep M Llovet","year":"2002","unstructured":"Llovet JM, Real MI, Monta\u00f1a X et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734\u20131739","journal-title":"The Lancet"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-019-06399-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-019-06399-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-019-06399-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T23:14:53Z","timestamp":1599174893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-019-06399-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,5]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["6399"],"URL":"https:\/\/doi.org\/10.1007\/s00330-019-06399-y","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,5]]},"assertion":[{"value":"18 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Reto Bale.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"Prof. Bale is a consultant for CAScination and i-Sys Medizintechnik.All other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Two of the authors (PS, EL) have significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 retrospective\u2022 case-control study\u2022 performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}